• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

APMIS . Reduced frequency of T helper 17 and T helper 1 cells and their association with critical coronavirus disease 2019

tetano

Editor, Senior Moderator
APMIS


. 2021 Mar 31.
doi: 10.1111/apm.13129. Online ahead of print.
Reduced frequency of T helper 17 and T helper 1 cells and their association with critical coronavirus disease 2019


Mehdi Shahbazi[SUP] 1 2 [/SUP], Mohammad Jafari[SUP] 3 [/SUP], Zahra Moulana[SUP] 4 [/SUP], Mahdi Sepidarkish[SUP] 5 [/SUP], Mojgan Bagherzadeh[SUP] 1 2 [/SUP], Maryam Rezanejad[SUP] 6 [/SUP], Mohammad Mirzakhani[SUP] 6 [/SUP], Mostafa Javanian[SUP] 5 [/SUP], Masomeh Bayani[SUP] 5 [/SUP], Mahmoud Sadeghi-Haddad-Zavareh[SUP] 5 [/SUP], Hamed Mehdinezhad[SUP] 7 [/SUP], Reza Ghadimi[SUP] 8 [/SUP], Mostafa Ghasemzadeh[SUP] 9 [/SUP], Ali Shokuhi Rad[SUP] 10 [/SUP], Mousa Mohammadnia-Afrouzi[SUP] 1 2 [/SUP]



Affiliations

Abstract

There is very little knowledge about the immune responses, particularly cellular immunity to coronavirus disease 2019 (COVID-19). The main objective of this study was to evaluate the frequency of T helper (Th) cell subtypes, including Th1, Th17, and Treg cells, in moderate-to-severe and critical COVID-19 patients compared to healthy controls. Twenty-nine moderate-to-severe and 13 critical patients confirmed for COVID-19, and 15 healthy subjects were included in this study. Interferon-? (IFN-?)-producing Th1 and interleukin-17A-producing Th17 and Treg cells in peripheral blood were measured with flow cytometry. The frequency of Th1 and Th17 was significantly decreased in critical patients compared to healthy subjects (aMD: -2.76 and - 2.34) and moderate-to-severe patients (aMD: -1.89 and - 1.89), respectively (p < 0.05). Differences were not significant between moderate-to-severe patients and healthy subjects for both Th1 (p = 0.358) and Th17 (p = 0.535), respectively. In contrast, significant difference was not observed between study subjects regarding the frequency of Treg cells. Patients with critical COVID-19 had a markedly lower Th1/Treg and Th17/Treg ratios compared with the controls and moderate-to-severe cases. Our study showed a dysregulated balance of Th1 and Th17 cells and its relation to the severity of COVID-19.

Keywords: Coronavirus disease 2019; T helper 1; T helper 17; Treg.
 
Back
Top Bottom